Dr. Jaja will study 100 adult patients at GHSU’s Sickle Cell Center in Augusta and satellite clinics in Albany, Macon, Savannah and Valdosta. He will define gene variations that determine how pain medications are metabolized and track emergency department visits and medication prescriptions. He thinks people with a gene that poorly or quickly metabolizes medication will visit the hospital more often.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
Spinal Modulation System Receives CE Mark for the Management of Chronic Intractable Pain
Medical Marijuana Used With Opiates Could Help Patients Reduce Pain
BioLineRx Drug Gets Positive Results in Clinical Trial for Neuropathic Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
